Nouvelle déclaration d'incident
No de la demande: 2011-1771
Numéro de référence du titulaire d'homologation: PROSAR Case # 1-25611901
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: KENTUCKY
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-139
Nom du produit: UltraGuard Plus Flea Tick Collar for Cats Kittens
Autre (préciser)
collarOui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Cat / Chat
Domestic long hair
1
Homme
2
7
lbs
Cutanée
Unknown / Inconnu
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Persisted until death
Non
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-25611901- The caller, a pet owner, indicated exposure of her animal to an insecticidal product containing the active ingredient tetrachlorvinphos. The pet owner stated she had placed the product, a flea and tick collar labeled for use on cats, on her two year seven pound male domestic long hair cat six days prior to her initial contact with the registrant. The day following application the caller had indicated the animal vomited in the morning and then several additional times through the day. Five days after application the pet owner noted salivation, and lethargy. The collar was removed and the animal brought to the veterinarian the next day due to loss of appetite and continued lethargy. The caller reports the animal had a seizure while at the veterinarian¿s office and its temperature was elevated (unspecified). The caller returned home with the animal and bathed it. The animal had another seizure at that point. The caller indicated an intention to return the animal to the veterinarians¿ office. The caller was advised of the unexpectedness of the signs seen and referred to the veterinarian for further care and assistance with diagnosis. The caller was advised of registrant supported cholinesterase screening. The same day the veterinarian had called to obtain information regarding cholinesterase screening. It was advised they thoroughly wash the animal and support it. On routine follow up two days later the pet owner advised the registrant that the animal had received atropine and improved. It was then sent home where it resumed seizures and salivating. The pet owner also reported muscle tremors and abnormal behavior. The animal was brought back to the veterinarian where intravenous medications were administered (unspecified) and the animal was hospitalized. Follow up was obtained from the owner five days after her initial contact. She indicated her animal had died the day prior and had been buried. Cholinesterase testing obtained from the Illinois Department of Agriculture Bureau of Animal Disease Laboratory indicated no cholinesterase depression in samples taken from this animal. No further information is available.
Mort